Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Fosamax 40 mg Distribution Plan Leaves Room For Once-Weekly Agent

Executive Summary

Merck's exclusive distribution program for patients receiving Fosamax 40 mg tablets for Paget's disease will give the company pricing flexibility when a once-weekly 35 mg formulation is approved for prevention of osteoporosis.

You may also be interested in...



Exclusive Rx Distribution Deals Will Limit Medicare Patient Access, Firms Say

Exclusive drug distribution arrangements will threaten Medicare beneficiaries' access to products, firms involved in assembling distribution networks under both Part B and Part D are telling the Centers for Medicare & Medicaid Services

Exclusive Rx Distribution Deals Will Limit Medicare Patient Access, Firms Say

Exclusive drug distribution arrangements will threaten Medicare beneficiaries' access to products, firms involved in assembling distribution networks under both Part B and Part D are telling the Centers for Medicare & Medicaid Services

Merck Fosamax Once-Weekly Is Priced Same Per Day As Its Daily Strengths

Merck's new once-weekly 70 mg Fosamax formulation is set at the same price per day of therapy as the daily 5 mg and 10 mg formulations of the osteoporosis drug.

Related Content

UsernamePublicRestriction

Register

PS036580

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel